These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16325708)

  • 1. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
    Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADRB1 and ADBR2 gene polymorphisms and the ocular hypotensive response to topical betaxolol in healthy Mexican subjects.
    Messina Baas O; Pacheco Cuellar G; Toral-López J; Lara Huerta SF; Gonzalez-Huerta LM; Urueta-Cuellar H; Rivera-Vega MR; Babayan-Mena I; Cuevas-Covarrubias SA
    Curr Eye Res; 2014 Nov; 39(11):1076-80. PubMed ID: 24749907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of betaxolol hydrochloride ophthalmic solution on intraocular pressures during transient microgravity.
    Pattinson TJ; Gibson CR; Manuel FK; Bishop SL; March WF
    Aviat Space Environ Med; 1999 Oct; 70(10):1012-7. PubMed ID: 10519481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
    Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost.
    Sakurai M; Higashide T; Takahashi M; Sugiyama K
    Ophthalmology; 2007 Jun; 114(6):1039-45. PubMed ID: 17467803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
    Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
    Johnson JA; Zineh I; Puckett BJ; McGorray SP; Yarandi HN; Pauly DF
    Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
    Olateju SO; Ajayi AA
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
    Zateyshchikov DA; Minushkina LO; Brovkin AN; Savel'eva EG; Zateyshchikova AA; Manchaeva BB; Nikitin AG; Sidorenko BA; Nosikov VV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease.
    Defoor J; Martens K; Zielinska D; Matthijs G; Van Nerum H; Schepers D; Fagard R; Vanhees L
    Eur Heart J; 2006 Apr; 27(7):808-16. PubMed ID: 16421173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
    Bruck H; Leineweber K; Temme T; Weber M; Heusch G; Philipp T; Brodde OE
    J Am Coll Cardiol; 2005 Dec; 46(11):2111-5. PubMed ID: 16325050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.
    Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
    Pharmacogenomics J; 2006; 6(3):174-8. PubMed ID: 16402084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents.
    Tafel J; Branscheid I; Skwarna B; Schlimme M; Morcos M; Algenstaedt P; Hinney A; Hebebrand J; Nawroth P; Hamann A
    Diabetes Obes Metab; 2004 Nov; 6(6):452-5. PubMed ID: 15479221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.